Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Precision oncology testing180.6M94.32%
Development services and other10.87M5.68%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States526.52M93.36%
International37.42M6.64%